Circulating Ang-2 mRNA expression levels: looking ahead to a new prognostic factor for NSCLC [corrected]

Non-small cell lung cancer (NSCLC) is the most common cancer and the leading cause of death from cancer worldwide. Antiangiogenic strategies directed towards tumor stroma are becoming gold standard in NSCLC treatment and researchers have been searching for biomarkers to identify patients for whom th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2014-02, Vol.9 (2), p.e90009-e90009
Hauptverfasser:	Coelho, Ana L, Araújo, António, Gomes, Mónica, Catarino, Raquel, Marques, Agostinho, Medeiros, Rui
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Analysis Angiogenesis Angiopoietin-2 - blood Angiopoietin-2 - genetics Antiangiogenic agents Antiangiogenics Biomarkers Biomarkers, Tumor - blood Biomarkers, Tumor - genetics Biopsy Cancer Cancer therapies Carcinoma, Non-Small-Cell Lung - blood Carcinoma, Non-Small-Cell Lung - diagnosis Carcinoma, Non-Small-Cell Lung - genetics Carcinoma, Non-Small-Cell Lung - mortality Care and treatment Chemotherapy Clinical trials Drug delivery Drug development Drugs Female Gene Expression Health aspects Humans Kinases Lung cancer Lung diseases Lung Neoplasms - blood Lung Neoplasms - diagnosis Lung Neoplasms - genetics Lung Neoplasms - mortality Male Medical prognosis Medical research Medicine Messenger RNA Metastasis Middle Aged Neoplasm Staging Nomograms Non-small cell lung cancer Non-small cell lung carcinoma Oncology Patients Peripheral blood Permeability Predictive Value of Tests Prognosis RNA, Messenger - blood RNA, Messenger - genetics Smoking Stroma Surgery Surgical instruments Survival Survival Analysis Tumors Vascular endothelial growth factor
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!